Life Science News

RSS

Start Codon closes venture fund at £15 million to support start-up companies in life sciences, healthcare space

Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP at £15 million.

From Start Codon Ltd 17 Nov 2020

Start Codon closes venture fund at £15 million to support start-up companies in life sciences, healthcare space

Start Codon, a life science and healthcare business accelerator based in Cambridge, UK, today announced that it has closed Start Codon Fund I LP at £15 million.

17 Nov 2020

First intratumoral injection approved by FDA for treating non-metastatic mast cell tumors in dogs

Today, the U.S. Food and Drug Administration approved Stelfonta (tigilanol tiglate injection) to treat dogs with non-metastatic, skin-based (cutaneous) mast cell tumors (MCTs).

17 Nov 2020

New mechanism controlling brain size discovered

Under the leadership of Professor Lars Allan Larsen and Professor Søren Tvorup Christensen at University of Copenhagen, Denmark, an international research team has taken an important step forward in understanding the complex mechanisms that control development of the so-called cerebral cortex, which is the part of the brain that play a key role in attention, perception, awareness, thought, memory, language, and consciousness.

16 Nov 2020

CMU researchers develop new technique for isolating brain cells associated with Parkinson's disease

Carnegie Mellon University researchers have developed a new technique for isolating a type of brain cell associated with Parkinson's disease symptoms, enabling them to study that cell type in detail.

16 Nov 2020

Sanger Institute and COG-UK get £12.2M funding to build genomic surveillance system for COVID-19

The Department for Health and Social Care Testing Innovation Fund has backed the Wellcome Sanger Institute and the COVID-19 Genomics UK Consortium in expanding whole genome sequencing of positive SARS-CoV-2 virus samples to map how COVID-19 spreads and evolves.

16 Nov 2020

Affinity-Bead Assisted Mass Spectrometry for Proteomics

In this interview, Ghaith Hamza from AstraZeneca talks to News-Medical Life Sciences about the basic principles of Affinity-Bead Assisted Mass Spectrometry (Affi-BAMS) and how Affi-BAMS can help target specific proteins for proteomic applications.

From Bruker Life Sciences Mass Spectrometry 16 Nov 2020

Researchers identify key source of signals encoding past experiences in the brain

Researchers identify a region of the brain as a key source of signals encoding past experiences in the neocortex.

16 Nov 2020

Patients' own stem cells can be used to grow new bones, study shows

A new, groundbreaking study from the University of Bergen shows that a patients' own stem cells can be used to grow new bone.

16 Nov 2020

Research provides insight into how Alzheimer’s plaques form

We are beginning to better understand how 'amyloid-β' protein plaques form, which are implicated in degenerative brain diseases including Alzheimer's and Parkinson's diseases.

16 Nov 2020

CEAT project for improving ovarian cancer diagnosis, treatment shows promise

Porvair Sciences reports, due to promising results, it has agreed with its collaborative partners to make additional investment in the CEAT project which aims to dramatically improve the diagnosis and treatment of ovarian cancer.

From Porvair Sciences Limited 16 Nov 2020

A-LabInsider introduces innovative app to boost biotech businesses

A-LabInsider has created an application that lists all academic life science labs in Europe with an intelligence to filter through them to make it easier for small and medium biotech companies to discover labs and do business with them.

16 Nov 2020

Tomocube’s HT-2 microscope quantifies therapeutic effects of targeted nanodrugs against atherosclerosis

Treatment of Atherosclerosis, the disease responsible for approximately half of all deaths in westernized societies, is a step closer following correlative studies using Tomocube’s HT-2 microscope.

From Tomocube Inc. 16 Nov 2020

Promising new compounds to potentially treat novel coronaviruses identified

Researchers at the University of Maryland School of Medicine and School of Pharmacy have discovered new drug compounds to potentially treat the novel coronavirus that causes COVID-19.

15 Nov 2020

Ovarian cancer project shows promise

Porvair Sciences reports, due to promising results, it has agreed with its collaborative partners to make additional investment in the CEAT project** which aims to dramatically improve the diagnosis and treatment of ovarian cancer.

From Chromatrap® - Porvair Sciences Ltd 13 Nov 2020

MIT researchers unravel the molecular structure of key coronavirus protein

MIT chemists have determined the molecular structure of a protein found in the SARS-CoV-2 virus. This protein, called the envelope protein E, forms a cation-selective channel and plays a key role in the virus's ability to replicate itself and stimulate the host cell's inflammation response.

12 Nov 2020

Study reveals a previously undetected repertoire of cancer driver genes

A new study, led by researchers from the University of California, Irvine, has deepened the understanding of epigenetic mechanisms in tumorigenesis and revealed a previously undetected repertoire of cancer driver genes.

12 Nov 2020

Neuroscientists identify astrocytes as master 'conductors' of the brain

In the orchestra of the brain, the firing of each neuron is controlled by two notes--excitatory and inhibitory-- that come from two distinct forms of a cellular structure called synapses.

12 Nov 2020

Researchers discover a mechanism that cells use to degrade microRNAs

UT Southwestern researchers have discovered a mechanism that cells use to degrade microRNAs (miRNAs), genetic molecules that regulate the amounts of proteins in cells.

12 Nov 2020

Brain's taste map operates differently than previously believed

What happens in our brain that makes us experience the sweet taste of a donut or the bitter taste of tonic water? What are the patterns of neural activity responsible for the perception of taste? A new study from Stony Brook University found that the map of neural responses mediating taste perception does not involve, as previously believed, specialized groups of neurons in the brain, but rather overlapping and spatially distributed populations.

12 Nov 2020

Life Science News

Start Codon closes venture fund at £15 million to support start-up companies in life sciences, healthcare space

Start Codon closes venture fund at £15 million to support start-up companies in life sciences, healthcare space

First intratumoral injection approved by FDA for treating non-metastatic mast cell tumors in dogs

New mechanism controlling brain size discovered

CMU researchers develop new technique for isolating brain cells associated with Parkinson's disease

Sanger Institute and COG-UK get £12.2M funding to build genomic surveillance system for COVID-19

Affinity-Bead Assisted Mass Spectrometry for Proteomics

Researchers identify key source of signals encoding past experiences in the brain

Patients' own stem cells can be used to grow new bones, study shows

Research provides insight into how Alzheimer’s plaques form

CEAT project for improving ovarian cancer diagnosis, treatment shows promise

A-LabInsider introduces innovative app to boost biotech businesses

Tomocube’s HT-2 microscope quantifies therapeutic effects of targeted nanodrugs against atherosclerosis

Promising new compounds to potentially treat novel coronaviruses identified

Ovarian cancer project shows promise

MIT researchers unravel the molecular structure of key coronavirus protein

Study reveals a previously undetected repertoire of cancer driver genes

Neuroscientists identify astrocytes as master 'conductors' of the brain

Researchers discover a mechanism that cells use to degrade microRNAs

Brain's taste map operates differently than previously believed

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest Life Science News